<qa>  What should be the interval from prior treatment to time of study drug administration?5. In the absence of rapidly progressing disease, the interval from prior treatment to time of study drug administration should be 2 weeks for cytotoxic agents or at least 5 half-lives for noncytotoxic agents. Persistent clinically significant toxicities from prior chemotherapy or radiotherapy must not be greater than Grade 1. 